Jim Simons Calliditas Therapeutics Ab Transaction History

Renaissance Technologies LLC

  • $63.6 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$15.04 - $26.32 $204,544 - $357,952
-13,600 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$21.03 - $33.19 $286,008 - $451,383
13,600 New
13,600 $294,000

Others Institutions Holding CALT

# of Institutions
24
Shares Held
871K
Call Options Held
1.5K
Put Options Held
32.4K
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.04B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email